Clinical Study of Regulatory T Cells (Tregs) in the Treatment of Neurodegenerative Diseases — StellaPhase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
China
The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Last updated September 2025